Results 71 to 80 of about 300,077 (226)
Clinical Case Reports, Volume 14, Issue 7, July 2026.ABSTRACT Systemic mastocytosis (SM) is a rare clonal myeloproliferative neoplasm typically characterized by cutaneous lesions and mediator‐release symptoms. Presentations dominated by visceral organ involvement without skin findings are uncommon and pose a significant diagnostic challenge, often mimicking hematologic malignancies.
Muhammad Sadam Zeb +9 more
wiley +1 more source
Autoimmunity and peginterferon therapy for polycythemia vera
HemaSphere, Volume 10, Issue 7, July 2026.Abstract Peginterferon‑α is useful to treat myeloproliferative neoplasms (MPNs) but can precipitate broad autoimmunity. By promoting beta‐cell, thyroid, and systemic immune injury, it can lead to Type 1 diabetes, autoimmune thyroiditis, systemic lupus erythematosus, or Sjögren's syndrome.
Etienne Rivière +8 more
wiley +1 more source
Myelopathy due to Spinal Extramedullary Hematopoiesis in a Patient with Polycythemia Vera
Case Reports in Orthopedics, 2017 Extramedullary hematopoiesis (EMH) occasionally occurs in patients exhibiting hematological disorders with decreased hematopoietic efficacy. EMH is rarely observed in the spinal epidural space and patients are usually asymptomatic.
Shuhei Ito +10 more
doaj +1 more source
Haematologica, 2019 Hydroxyurea is the standard treatment in high-risk patients with polycythemia vera. However, estimates of its effect in terms of clinical outcomes (thrombosis, bleeding, hematologic transformations and mortality) are lacking. We performed a meta-analysis
A. Ferrari +7 more
semanticscholar +1 more source
Respirology Case Reports, Volume 14, Issue 7, July 2026.Time course of haemoglobin (red, left axis) and serum erythropoietin (blue, right axis) before and after hysterectomy with bilateral salpingo‐oophorectomy (BSO, green vertical line, 31 July 2025), showing normalization of both parameters following tumour resection.
Venkatkiran Kanchustambham +3 more
wiley +1 more source
Haematologica, 2011 We tested the hypothesis that levels of pentraxin high sensitivity C-reactive protein and pentraxin 3 might be correlated with cardiovascular complications in patients with essential thrombocythemia and polycythemia vera.
Tiziano Barbui +15 more
doaj +1 more source
Trends in Research, 2019 Leukemia is a cancer of the blood and bone marrow; there are many types of leukemia, depending on which type of white blood cell is involved. Treatment varies with the type and stage of disease.
A. Heidari, R. Gobato
semanticscholar +1 more source
British Journal of Haematology, Volume 209, Issue 1, Page 160-171, July 2026.Summary This UK‐based retrospective analysis describes real‐world treatment patterns and outcomes in 175 patients with accelerated (AP, n = 69) or blast‐phase (BP, n = 106) ‘Philadelphia‐negative’ myeloproliferative neoplasms (MPN‐AP/BP) diagnosed between 2013 and 2025. Median age at transformation was 71 years.
Alexandros Rampotas +35 more
wiley +1 more source
Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis
Haematologica, 2019 Here we critically evaluate the role of elevated hematocrit as the principal determinant of thrombotic risk in polycythemia and erythrocytosis, defined by an expansion of red cell mass.
Victor R. Gordeuk +2 more
doaj +1 more source
Transient Spinal Cord Ischemia as Presenting Manifestation of Polycythemia Vera
Case Reports in Neurology, 2011 Spinal arterial vascularization is supplied by a large anastomotic net, making spinal ischemic events far less common than ischemic cerebral strokes. Polycythemia vera, due to blood hyperviscosity and activated platelet aggregation, is associated with a ...
Sónia Costa +3 more
doaj +1 more source